Skip to main content
. 2021 Jul 9;12:707776. doi: 10.3389/fphar.2021.707776

FIGURE 4.

FIGURE 4

miRNA biomarkers in UC. Blood, stool and tissue-based miRNA biomarkers might be used for the diagnosis, monitoring, prognosis of UC and the prediction of early stage CAC, as well as to guide clinical treatment and medication strategies. miRNA biomarkers could be of value in improving survival and cure rates in UC and CAC patients.